Maastricht, The Netherlands, April 21, 2015 / B3C newswire / -- Cristal Therapeutics, a privately-held life sciences company developing novel nanotherapeutics against cancer and other diseases, by using its patented CriPec® platform announced today the …
Mymetics virosome vaccine technology and HIV vaccine candidate to be used as basis to develop a scalable manufacturing process within 3.5 years Funding this project can represent a major innovation in the world of vaccine as more than 90% of the existing …
Aubagne, France, April 17, 2015 / B3C newswire / -- Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industries, today acquired the Scottish company BioOutsource Ltd. The privately owned company based in Glasgow, …
Takeover expands SSB’s service portfolio Glasgow, UK, April 17, 2015 / B3C newswire / -- BioOutsource Ltd. (BioOutsource), a leading provider of contract testing services for the biopharmaceutical industry, has been acquired by Sartorius Stedim Biotech ( …
Krakow, Poland, April 17, 2015 / B3C newswire / -- Selvita (WSE:SLV), the largest drug discovery company in Central and Eastern Europe, will publish the most recent data from its oncology programs at the upcoming AACR Annual Meeting 2015, which will take …
Munich, Germany, April 16, 2015 / B3C newswire / -- Isarna Therapeutics, the leader in transforming growth factor beta (TGF-ß) targeted antisense therapeutics, announced today the initiation of a Phase I clinical trial with ISTH0036, an antisense …
évolis ONE, Cellmid’s novel FGF5 inhibitor hair growth product has been tested in a blinded, placebo-controlled clinical study with outstanding results évolis ONE has demonstrated efficacy in reducing hair loss, increasing hair growth and improving hair …
Single-use clarification system eliminates centrifuges High cell density harvesting performed in a single step Process robustness and predictability ensured Goettingen, Germany, April 14, 2015 / B3C newswire / --Sartorius Stedim Biotech (SSB), a leading …
Heidelberg, Germany, April 14, 2015 / B3C newswire / -- What a difference between the first euroPLX Partnering Conference on June 20, 1995, and the 58th that will be held on June 1 + 2, 2015, in Munich, Germany! Then, barely anyone had an email address to …
TVM Capital Life Science to open new office in Hong Kong with Dr. Mirko Scherer as Managing Partner Munich/Hong Kong, April 13, 2015 / B3C newswire / -- TVM Capital Life Science announced today that it has achieved the first closing of China BioPharma …
São Paulo, Brazil, April 10, 2015 / B3C newswire / -- The Brazilian National Technical Commission on Biosafety (CTNBio) today approved the commercial use of the yield enhanced eucalyptus developed by FuturaGene, a wholly owned subsidiary of Suzano Pulp …
Hudson, NY, USA, April 9, 2015 / B3C newswire / --These events are scheduled for the week of April 13, 2015, in Washington, D.C., San Diego and San Francisco. Expert speakers from industry, academia and government will present during the half-day events. …
Company Also Highlights FDA Clearance of MammaPrint in FFPE Irvine, CA, USA and Amsterdam, The Netherlands, April 8, 2015 / B3C newswire / -- Agendia, a leading molecular diagnostics company that develops and markets genomic diagnostic products, announced …
Role with company commenced on April 1, 2015 Ravensburg, Germany, April 8, 2015 / B3C newswire / -- Vetter, a leading contract development and manufacturing organization that specializes in aseptic manufacturing, today announced that the company’s Advisory …
Vienna, Austria and Küssnacht, Switzerland, April 8, 2015 / B3C newswire / - Today AOP Orphan Pharmaceuticals AG, Austria, and Rigi Healthcare AG, Switzerland, announced the creation of Rigi Orphan Inc, USA. The new company will focus on the development, …
Test offers high sensitivity and specificity for pathogenic C. difficile and highly accurate differentiation of the hypervirulence-associated 027 ribotype Espoo, Finland, April 8, 2015 / B3C newswire / -- Mobidiag Ltd, a Finnish molecular diagnostics …
Krakow, Poland, March 31, 2015 / B3C newswire / -- Selvita (WSE:SLV), the largest drug discovery company in Central and Eastern Europe, announced today that it is commencing IND-enabling studies for SEL24 project, the company’s first oncology drug …
Breakthrough potential as affordable NIPT solution on global basis Constance, Germany, March 26, 2015 / B3C newswire / -- LifeCodexx AG today reports the successful outcome of a proof-of-principle of its novel assay for non-invasive prenatal testing (NIPT …
Successfully Completed Phase I Clinical Study and Regulatory Approval Enable World’s First Genetically-Engineered Cell Therapy to Enter Phase II Munich, Germany, March 26, 2015 / B3C newswire / -- apceth, a global leader in engineered cell therapies, today …
Novel Technology Will Improve Process of Generating Cells from Patient-Derived Tumors Hudson, NY, USA, March 26, 2015 / B3C newswire / -- Taconic Biosciences and Cellaria Biosciences today announced that the two companies have entered into a scientific …
